Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | €9.00 | €17.64 | 95.974% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €21.60 | - | - |
| Iovance Biotherapeutics Inc. | 21 | 3 | 1 | 0 | €7.70 | €26.24 | 240.727% |
| United Therapeutics | 19 | 0 | 0 | 0 | €255.50 | €287.40 | 12.486% |
| Blueprint Medicines Corp | 2 | 0 | 0 | 0 | €95.34 | - | - |
| Xencor Inc. | 10 | 1 | 0 | 0 | €21.80 | €32.58 | 49.444% |
| Charles River Labs Intl | 10 | 0 | 0 | 0 | €188.70 | €248.57 | 31.728% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.37 | €26.01 | 27.670% |
| Neurocrine Bioscience | 31 | 0 | 2 | 0 | €127.80 | €140.60 | 10.018% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €49.80 | €55.00 | 10.453% |
| Repligen Corp. | 13 | 0 | 0 | 0 | €140.00 | €184.76 | 31.971% |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | €137.90 | €236.30 | 71.355% |
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €5.66 | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.31 | €3.70 | 181.583% |
| Halozyme Therapeutics Inc. | 15 | 0 | 0 | 0 | €40.57 | €47.17 | 16.268% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €353.90 | €419.64 | 18.575% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €34.80 | €38.99 | 12.036% |
| Ultragenyx Pharmaceutical Inc. | 21 | 1 | 4 | 0 | €37.00 | €84.74 | 129.038% |
| PTC Therapeutics Inc. | 15 | 8 | 0 | 1 | €33.00 | €41.51 | 25.795% |